CME/CE Accreditation Information Return to Previous

TITLE: Unlocking the Potential: Advancements in ADC Therapy for Metastatic Triple Negative and HER+/HER2- Breast Cancer Treatment

 

Release Date: December 6, 2024

Expiration Date:  December 6, 2025


STATEMENT OF NEED

Breast cancer continues to be a leading cause of cancer-related deaths globally, with HER2-positive, HER2-low, and triple-negative breast cancer (mTNBC) presenting unique challenges. Antibody-drug conjugates (ADCs) are transforming the treatment landscape, offering targeted therapy options that improve efficacy while reducing systemic toxicity. Despite these advancements, many HCPs face challenges in understanding how to incorporate ADCs into clinical practice, including selecting the right patients, sequencing treatments, and managing side effects. This curriculum is designed to close those gaps, equipping participants with the latest evidence and practical tools to optimize care for patients with these challenging breast cancer subtypes.



EDUCATIONAL OBJECTIVES
 

  1. APPLY data from recent clinical trials using ADCs in the treatment of TNBC to sequencing strategies in patient care
  2. OPTIMIZE treatments for patients with HR+/HER2- breast cancer using data from recent clinical trials of ADCs
  3. DEVELOP a plan to monitor for and manage AEs in patients with breast cancer treated with ADCs, in order to avoid interruptions in care

 

 


TARGET AUDIENCE:

This educational initiative is intended for medical oncologists and oncology nurse practitioners (NPs) and physician associates (PAs) who care for patients with breast cancer.

 

FACULTY 

 

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology, Susan F. Smith Center for Women's Cancers
Associate Director, Susan F. Smith Center for Women's Cancers
Associate Professor of Medicine, Dana Farber Cancer Institute

 

 

David B. Page, MD

Medical Oncologist
Clinical Investigator
Providence Cancer Institute

 


CONTENT REVIEWER

Victor B. Hatcher, PhD

 

DISCLOSURE OF FINANCIAL RELATIONSHIPS
The “Policy on Identification, Mitigation, and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that any individual in control of content, including faculty, participating in CME activities disclose to the audience all relevant financial relationships with ineligible companies* in the past 24 months. Any individual in control of content who refuses to disclose, or whose disclosed relationships prove to create a conflict of interest, will be recused.

Individuals with the absence of relevant financial relationships with ineligible companies will be disclosed to the audience.

 

All financial relationships of individuals in a position to control the content of this CME activity are identified and mitigated prior to the educational activity.
 

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

Faculty Disclosure(s)

Victor B. Hatcher, PhD has no relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.

David B. Page, MD, has no relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.

Sara M. Tolaney, MD, MPH has no relevant financial relationships with ACCME-defined ineligible companies during the past 24 months.

 

PROVIDERSHIP

This educational activity is jointly provided by Albert Einstein College of Medicine-Montefiore Medical Center and RealCME.  

 


ACCREDITATION STATEMENT


In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and RealCME, LLC. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CREDIT DESIGNATION STATEMENT
Albert Einstein College of Medicine-Montefiore Medical Center designates this other activity (blended live and enduring curriculum) for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
 

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit from organizations accredited by the ACCME.
 

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.25 hours of Category 1 credit for completing this program.
 

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

DISCLOSURE OF UNLABELED USE
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.

 

DISCLAIMER
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine-Montefiore Medical Center, RealCME or Jazz Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

 

 

METHOD OF PARTICIPATION/INSTRUCTIONS ON HOW TO RECEIVE CREDIT

Estimated time to complete this activity:  4 hours and 45 minutes


To obtain credit, a score of 70% or better on the Final Assessment is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this curriculum, answered all test questions, completed the Final Assessment, Post Group Assessment, and evaluation, and have received a digital copy of your credit certificate.

 

  • Baseline/Final Assessments: 30 minutes each for a total of up to 1.00 hour of CME 
  • Six (6) Self-Study Modules: 7-8 minutes each for a total of up to 0.75 hour of CME 
  • Two (2) Live Group Discussions: 45 minutes each for a total of up to 1.50 hour of CME 
  • Two Group Challenges (2): 30 minutes each for a total of up to 1.00 hour of CME 
  • Action Plan (1) development: 30 minutes for a total of up to 0.50 hour of CME


If you are seeking credit, you must complete the assessment and evaluation at the conclusion of the activity. Your certificate can be printed immediately.



PRIVACY STATEMENT
Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development (Einstein-Montefiore) protects the privacy of personal and other information regarding participants and education collaborators. Einstein-Montefiore will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting to the ACCME. Einstein-Montefiore maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.


COLLECTION AND USE OF YOUR PERSONAL INFORMATION
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, middle initial, degree, email address, address and phone number. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected, retained, and used by Einstein-Montefiore to continuously improve the learning experience. Einstein-Montefiore will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Einstein-Montefiore will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.


CONTACT INFORMATION
For questions regarding CME credit, contact Albert Einstein College of Medicine-Montefiore Medical Center at cme@montefiore.org.

For technical questions related to this activity, please contact support@gathered.com.

 

ACKNOWLEDGEMENT OF FINANCIAL SUPPORT
This program is supported by an independent medical education grant from Jazz Pharmaceuticals.